Reaction Biology (Germany)
The German arm of Reaction Biology, a consultative drug discovery and development CRO with sites in Freiburg and Heidelberg.
Last updated September 27, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Reaction Biology (Germany) is the German operating arm of Reaction Biology, a consultative contract research organization (CRO) that supports pharmaceutical, biotechnology, and academic teams across drug discovery, preclinical, and clinical development. The German entity is associated with the company's European operations, which are based in Freiburg and Heidelberg, and it operates under the Reaction Biology Europe banner. Reaction Biology as a whole traces its origins to 2001 and describes more than 25 years of scientific experience, positioning itself as a single partner that can carry a program from early discovery through preclinical and clinical milestones. The company's service portfolio spans biochemical, cellular, and biophysical assays; in vitro safety testing; in vivo pharmacology and immuno-oncology studies; and GMP-compliant bioassays. Its target library is a core differentiator: the company states that it maintains the industry's largest kinase assay library, alongside hundreds of validated proteins and more than 1,000 cell lines. Reaction Biology Europe operates under an ISO 9001:2015-certified quality management system covering the development, production, and sale of recombinant protein products, biochemical, cellular, and immuno-oncology assay services, and in vivo testing services. BSL2-equipped laboratories support in vivo efficacy studies across modalities including small molecules, antibodies, antibody-drug conjugates (ADCs), and oncolytic viruses. Reaction Biology is headquartered in the United States and operates four sites across North America and Europe. Its research hubs include Malvern and Hershey, Pennsylvania, in the United States, and Freiburg and Heidelberg in Germany. The German sites host roles in assay development and validation, laboratory operations, and specialized scientific functions, reflecting the group's European footprint. The company serves a global customer base and reports that its data has contributed to the advancement of hundreds of novel oncology programs through IND submission. As a brand, Reaction Biology (Germany) is best understood as the European operational identity of a US-headquartered CRO rather than a standalone consumer-facing company. Its value proposition rests on consultative scientific partnership, rapid responsiveness, and rigorous data quality, with the German sites providing assay services, in vivo testing, and related capabilities to European and international clients.
History
Reaction Biology traces its beginnings to 2001, when it was established as a drug discovery services provider. Over more than two decades it grew into a consultative CRO serving pharmaceutical, biotechnology, and academic clients. The company's European presence took shape through operations in Germany, with sites in Freiburg and Heidelberg that became part of the group's four-site network across North America and Europe. Reaction Biology Europe operates under an ISO 9001:2015-certified quality management system covering recombinant protein products, biochemical, cellular, and immuno-oncology assay services, and in vivo testing services. The German entity is recorded as a company in Freiburg, Germany. The group is headquartered in the United States, with research hubs in Malvern and Hershey, Pennsylvania, and in Freiburg and Heidelberg, Germany. Reaction Biology states that it has more than 25 years of scientific experience and that its data has contributed to the advancement of hundreds of novel oncology programs through IND submission. Its capabilities have expanded to include biochemical, cellular, and biophysical assays; in vitro safety testing; in vivo pharmacology and immuno-oncology studies; and GMP-compliant bioassays, supported by BSL2-equipped laboratories and a target library that includes the industry's largest kinase assay library.
- 2001
Reaction Biology founded as a drug discovery services provider.
European operations established with sites in Freiburg and Heidelberg, Germany.
Reaction Biology Europe operates under an ISO 9001:2015-certified quality management system.
Products and positioning
Consultative CRO elevating the standard for data quality and scientific partnership, supporting programs from discovery through clinical development.
Kinase assay library
Described as the industry's largest kinase assay library.
Biochemical, cellular, and biophysical assays
Core assay services for drug discovery.
In vitro safety testing
Safety testing services for preclinical development.
In vivo pharmacology and immuno-oncology studies
In vivo efficacy studies supported by BSL2-equipped labs.
GMP-compliant bioassays
Bioassays compliant with GMP standards.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/reaction-biology-germany · Editorial policy · How profiles are compiled